// App-Quantinova.ai

TCT-687 : Paravalvular leak in the RESPOND post-market study: predictors and impact on 2-year clinical outcomes following TAVR with a fully repositionable and retrievable aortic valve in routine clinical practice

Researchers

Presenter

  • Jochen Wohrle

Principal Investigators

  • Daniel Blackman

  • Mohamed Abdel-Wahab

  • David Hildick-Smith

  • Sabine Bleiziffer

  • Dominic Allocco

  • Ian Meredith

  • Volkmar Falk

  • Nicolas Van Mieghem

Medical Centers

  • Leeds General Infirmary, Leeds, United Kingdom

  • Royal Sussex County Hospital, Brighton, United Kingdom

  • University Hospital Ulm, Ulm, Germany

  • Deutsches Herzzentrum Berlin, Klinik für Herz-Thorax-Gefässchirurgie, Berlin, Germany

  • Heart Center Leipzig, University Hospital, Leipzig, Germany

  • German Heart Center Munich, Munich, Germany

  • Thorax Center, Erasmus Medical Center, Rotterdam, Netherlands

Locations

  • United Kingdom

  • United States

  • Germany

  • Netherlands

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Aortic regurgitation

  • Paravalvular regurgitation

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved